TrialThe Lancet. Oncology2017

Binimetinib versus dacarbazine in patients with advanced NRAS-mutant melanoma (NEMO): a multicentre, open-label, randomised, phase 3 trial.

Reinhard Dummer et al.PubMed ↗Publisher ↗

No numbers read from the abstract.